| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/09/1997 | WO1997000663A1 Composition including a dispersion of polymeric particles in a non-aqueous medium |
| 01/09/1997 | WO1997000638A2 Apparatus and method for making gas-filled vesicles of optimal size |
| 01/09/1997 | WO1997000623A1 Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals |
| 01/09/1997 | DE19524083A1 Verfahren zur Herstellung von Wirkstoffen aus ungebrauchten bzw. abgelegten Vorrichtungen zur transdermalen Applikation von Wirkstoffen und/oder deren Produktionsabfällen Process for the preparation of active substances from unused or discarded devices for the transdermal application of active substances and / or their production waste |
| 01/09/1997 | CA2225415A1 Tar-containing composition and pharmaceutical and cosmetic preparation containing the same |
| 01/09/1997 | CA2224798A1 Stable hydroalcoholic compositions |
| 01/09/1997 | CA2224702A1 Stable hydroalcoholic compositions |
| 01/09/1997 | CA2222455A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 01/08/1997 | EP0752457A2 Hydrophilic adhesive base material |
| 01/08/1997 | EP0752391A2 Water for medical treatment, production method thereof and dialysis apparatus using same |
| 01/08/1997 | EP0752245A1 Biocompatible and biodegradable nanoparticles designed for proteinaceous drugs absorption and delivery |
| 01/08/1997 | EP0752243A2 Container filled with infusion liquids |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0752002A1 Inhibition of arterial smooth muscle cell proliferation |
| 01/08/1997 | EP0751947A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity |
| 01/08/1997 | EP0751789A1 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 01/08/1997 | EP0751785A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 01/08/1997 | EP0751778A1 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same |
| 01/08/1997 | EP0751776A1 Novel pharmaceutical composition for skin diseases |
| 01/08/1997 | EP0751771A1 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant |
| 01/08/1997 | EP0751766A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 01/08/1997 | EP0751760A1 Method for the treatment and/or prevention of radiation burn |
| 01/08/1997 | EP0620728B1 Preparation of tablets of increased strength |
| 01/08/1997 | EP0591204B1 Pharmaceutical formulations |
| 01/08/1997 | EP0583244B1 Method of producing zero-order controlled-release devices |
| 01/08/1997 | EP0568577B1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 01/08/1997 | EP0558586B1 A gel-forming liquid carrier composition |
| 01/08/1997 | EP0558571B1 Method of making oil filled paucilamellar lipid vesicles |
| 01/08/1997 | EP0551411B1 Ionically cross-linked polymeric microcapsules |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139946A Use of bicontinuous microemulsions as pressure sensitive adhesives |
| 01/08/1997 | CN1139881A Aqueous topical compositions |
| 01/08/1997 | CN1139878A Intraorally soluble compressed molding and process for producing the same |
| 01/08/1997 | CN1139877A Rapidly dissolving oral dosage form |
| 01/08/1997 | CN1139578A Making method for insulin suppository |
| 01/08/1997 | CN1139575A Wugushen rice bag |
| 01/08/1997 | CN1139571A Ointment for burns made of Saussurea Involucrata |
| 01/08/1997 | CN1139570A Adhesive plaster for stomach-ache |
| 01/08/1997 | CN1139569A Adhesive plaster for neurasthenia |
| 01/08/1997 | CN1139565A Nourishing medicine for preventing and curing toxic and side effect after tumor radiotherapy and chemotherapy and preparation method |
| 01/08/1997 | CN1139561A Heart disease medicine made of melon net |
| 01/08/1997 | CN1139559A Adhesive plaster for wound |
| 01/08/1997 | CN1139549A Convenient traditional Chinese medicine and medicinal food material and making method |
| 01/07/1997 | US5591820 Polyurethane pressure-sensitive adhesives |
| 01/07/1997 | US5591767 Liquid reservoir transdermal patch for the administration of ketorolac |
| 01/07/1997 | US5591732 Administering 4-chloro-1-dehydromethyltestosterone and/or mestanolone to treat osteoporosis |
| 01/07/1997 | US5591731 Crystalline amifostine compositions |
| 01/07/1997 | US5591710 Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
| 01/07/1997 | US5591456 Adsorption on hydroxypropyl cellulose |
| 01/07/1997 | US5591455 Wet powder film-forming compositions |
| 01/07/1997 | US5591454 Administering glipizide |
| 01/07/1997 | US5591453 Incorporation of biologically active molecules into bioactive glasses |
| 01/07/1997 | US5591452 Controlled release formulation |
| 01/07/1997 | US5591451 Oil-based tableting method |
| 01/07/1997 | US5591450 L-carnitine salt and compositions containing same |
| 01/07/1997 | US5591449 Vesicles, and cosmetic or pharmaceutical compositions containing vesicles, bounded by one or more lamellae composed of a lipid phase containing fluorine-containing, polyglycerolated amphilic sulphur compounds |
| 01/07/1997 | US5591448 Liposome, viral receptor protein |
| 01/07/1997 | US5591445 For stimulating peristaltic contractions of intestines, barium chloride or neurotransmitter dispersed in silicone matrix |
| 01/07/1997 | US5591441 Composition for nonspecific cellular immune stimulation |
| 01/07/1997 | US5591436 Composition for a dietary supplement for the treatment of hemorrhoids |
| 01/07/1997 | US5591433 Oral administration of immunologically active biomolecules and other therapeutic proteins |
| 01/07/1997 | US5591426 Polyvinylpyrrolidone, hydroxypropyl methylcellulose, buffer, glycerin, preservative |
| 01/07/1997 | CA2111122C Aqueous emulsions & aerosol delivery system using same |
| 01/07/1997 | CA2070803C Biodegradable implant material and process for producing same |
| 01/07/1997 | CA2038097C Method and composition for coiontophoresis |
| 01/07/1997 | CA2029050C Sustained release compositions for treating periodontal disease |
| 01/07/1997 | CA2025315C Protein-containing aqueous solutions |
| 01/07/1997 | CA2008509C Stabilizing system for solid dosage forms |
| 01/07/1997 | CA2004309C Cosmetic or pharmaceutical composition for the treatment of hair and scalp |
| 01/05/1997 | CA2180084A1 Hydrophilic adhesive base material |
| 01/03/1997 | WO1997000241A1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 01/03/1997 | WO1997000080A1 Pharmaceutical preparation with cyclosporin a |
| 01/03/1997 | WO1996037283A3 Method and device for delivering a substance |
| 01/03/1997 | CA2224566A1 New cationic and polycationic amphiphiles, reagents containing them and their use |
| 01/02/1997 | EP0751150A1 Cyclodextrin derivatives, their preparation and their use to incorporate hydrophobic molecules in organized surfactant systems |
| 01/02/1997 | EP0750913A2 Disaccharide containing freeze-dried preparation for pharmaceutical use |
| 01/02/1997 | EP0750910A1 Liposome preparation |
| 01/02/1997 | EP0750907A2 Stable macrolide and macrolide vaccine compositions |
| 01/02/1997 | EP0750905A2 Patch comprising water soluble adhesive sheet |
| 01/02/1997 | EP0750854A2 Process for encapsulating a core material with a polymer by high-pressure treatment |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750604A1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
| 01/02/1997 | EP0750515A1 Low molecular weight hyaluronic acid with peptide or protein |
| 01/02/1997 | EP0750506A1 Broad spectrum antimicrobial compounds and methods of use |
| 01/02/1997 | EP0750495A1 Delivery systems for hydrophobic drugs |
| 01/02/1997 | EP0750494A1 Hydrophobic drug delivery systems |
| 01/02/1997 | EP0750493A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
| 01/02/1997 | EP0750492A1 Inhalation composition containing lactose pellets |
| 01/02/1997 | EP0619743B1 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 01/02/1997 | EP0484448B2 Process for producing organised powders by spraying from at least two sets of particles |
| 01/02/1997 | DE19625027A1 Medicament prepn. for prodn. of propellant gas-free aerosol |
| 01/02/1997 | DE19522694A1 Teerhaltige Zusammensetzung und diese enthaltende pharmazeutische und kosmetische Zubereitung Tar-containing composition containing them and pharmaceutical and cosmetic preparation |
| 01/02/1997 | DE19522693A1 Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung A composition for preparing a finely dispersed systems and methods for their preparation |
| 01/01/1997 | CN1139386A Microcapsules, method of making and their use |
| 01/01/1997 | CN1139385A Aqueous prolonged release formulation |
| 01/01/1997 | CN1139384A Use of mometasone furoate for treating airway passage and lung diseases |